Related references
Note: Only part of the references are listed.Aripiprazole, an atypical antipsychotic prevents the motor hyperactivity induced by psychotomimetics, and psyphostimulants in mice
Juliana V. Leite et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Controversies in translational research: drug self-administration
Margaret Haney et al.
PSYCHOPHARMACOLOGY (2008)
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration
Sunmee Wee et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance
William W. Stoops et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2007)
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine
William W. Stoops et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans
JA Lile et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Aripiprazole in schizophrenia with cocaine dependence - A pilot study
TP Beresford et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole
ES Brown et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans
CR Rush et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
JM Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Pharmacological treatment of cocaine dependence: a systematic review
MS de Lima et al.
ADDICTION (2002)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)